Loading...
Chemical structure of Everolimus

GC13601

Everolimus

Also listed as Everolimus (RAD001)

Everolimus (RAD001) is an orally active derivative of rapamycin that inhibits the Ser/Thr kinase, mTOR (mammalian target of rapamycin)

ChemicalCAS159351-69-6MW958.22FormulaC53H83NO14
CAS number
159351-69-6
Molecular weight
958.22
Formula
C53H83NO14
Solubility
≥ 47·911mg/mL in DMSO, ≥ 122 mg/mL in EtOH
InChIKey
HKVAMNSJSFKALM-GKUWKFKPSA-N
Catalogue number
GC13601
Brand
GLPBIO
Computed properties PubChem CID 6442177 · XLogP 5.9 · TPSA 205 Ų · H-bond donors 3
XLogP
5.9
TPSA
205 Ų
H-bond donors
3
H-bond acceptors
14
Rotatable bonds
9
Heavy atoms
68

SMILES C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC

Computed descriptors from PubChem (CID 6442177), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.